首页 正文

Xenopax for the treatment of steroid-refractory acute graft-versus-host disease: the RELAX study

{{output}}
Background: Steroid-refractory (SR) acute graft-versus-host disease (aGVHD) is the major cause of early mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Xenopax, a novel and the only available human... ...